Therapeutic efficacy of erythropoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis.
Erythropoietin (EPO) has neuroprotective effects in many models of damage and disease of the nervous system where neuroinflammation plays a substantial role, including experimental autoimmune encephalomyelitis (EAE), the animal model of multiple sclerosis (MS). Since the first pioneering studies, in...
Main Authors: | Cervellini, I, Ghezzi, P, Mengozzi, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|
Similar Items
-
Therapeutic efficacy of erythrpoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis
by: Cervellini, I, et al.
Published: (2013) -
Endogenous erythropoietin as part of the cytokine network in the pathogenesis of experimental autoimmune encephalomyelitis.
by: Mengozzi, M, et al.
Published: (2008) -
Erythropoietin does not affect TNF and IL-6 production directly.
by: Cervellini, I, et al.
Published: (2013) -
Systemic Acrolein Elevations in Mice With Experimental Autoimmune Encephalomyelitis and Patients With Multiple Sclerosis
by: Melissa Tully, et al.
Published: (2018-06-01) -
Editorial: Pain in multiple sclerosis and experimental autoimmune encephalomyelitis
by: Amy Lovett-Racke, et al.
Published: (2022-11-01)